Roche Palo Alto is dedicated to discovering and developing new medicines that improve the lives of people with inflammatory or viral disease. We are one of five global research sites for the Swiss-based healthcare company Roche, and it is here that our 1,000 scientists and staff lead the discovery, development and strategic marketing of medicines that can improve the lives of people affected by serious illness. We do this in a responsible and ethical manner with a commitment to sustainable development respecting the needs of the individual, society and environment.

Roche Palo Alto offers the best of two worlds: the flexibility and vigor of a small biotechnology company and the resources and rigor of a large, multi-national pharmaceutical corporation.